Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 82

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 82
---
2025 Proxy Statement•Executive Compensation |

Analysis of the Information Presented in the Pay Versus Performance Table While Humana uses several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the Pay versus Performance Table set forth herein. Moreover, Humana generally seeks to incentivize long-term performance, and therefore does not specifically align the Company’s performance measures with compensation that is actually paid (as computed in accordance with PvP Rules) for a particular year. In accordance with the PvP Rules, Humana is providing the following descriptions of the relationships between information presented in the Pay versus Performance Table.

Compensation Actually Paid and Adjusted EPS

The following graphs depict the relationship between EPS and CAP to Humana’s CEOs and the NEOs, respectively.

Compensation Actually Paid and Net Income

The following graphs depict the relationship between Net Income and CAP to Humana’s CEOs and the NEOs, respectively.

Compensation Actually Paid and Relative TSR

The following graphs depict the relationship between TSR and CAP to Humana’s CEOs and the NEOs, respectively.

| Executive Compensation•2025 Proxy Statement | Humana |     | 81 |

Certain Transactions with Management and Others The Board of Directors has determined that there are no material transactions involving a current director or director nominee of the Company. For a discussion of the transactions reviewed, please see the discussion under “Independent Directors” herein. The Board of Directors has reviewed the following transactions involving executive officers and a 5% or greater stockholder:

| • |     | The Johns Hopkins Hospital. The Company had a business relationship with The Johns Hopkins Hospital healthcare system, of which an immediate family member of our executive officer James A. Rechtin is employed. The Johns Hopkins Hospital is a provider in our network for which we paid approximately $17.81 million in medical claims during 2024, which is an amount that is comparable to non-affiliated providers for the provision of similar services. The amount paid is not material to the Company and does not represent a direct or indirect material interest to Mr. Rechtin. |

| • |     | U.S. Anesthesia Partners. The Company had a business relationship with U.S. Anesthesia Partners, of which an immediate family member of our executive officer James A. Rechtin is employed. U.S. Anesthesia Partners is a provider in our network for which we paid approximately $24.66 million in medical claims during 2024, which is an amount that is comparable to non-affiliated providers for